Mounjaro 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FQ93V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,209
Award facts
- Contract value 100% obligated
- $27,209.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,209 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pen (semaglutide injection), a diabetes and weight management medication. The contract, issued on September 26, 2025, with completion targeted for September 29, 2025, represents a competitively awarded, non-set-aside order performed at the contractor's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates significant capability in delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order exemplifies the operational flexibility of the DLA's prime vendor contracting approach, which strategically leverages established pharmaceutical distributors to ensure reliable supply of critical medications to military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FQ93V?
SPE2DB25FQ93V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FQ93V worth?
The government has obligated $27,209 on SPE2DB25FQ93V.
Is contract SPE2DB25FQ93V an order under another contract?
Yes. SPE2DB25FQ93V is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ93V competed?
The extent of competition for SPE2DB25FQ93V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award